Immunological and Virucidal effect of Amrita Tablet for Prevention of HIV AIDS

A study to investigate the antiretroviral drug in Ayurveda. - Nill

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062079

Enrollment

500

Registered

2024-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R760- Raised antibody titer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosis to be HIV Positive

Exclusion criteria

Exclusion criteria: Taking immunomodulatory drugs Patient of antiretroviral Therapy Pregnancy or lactation Children

Design outcomes

Primary

Measure	Time frame
Increasing Ojas immune function to decrease viral load. Timepoint: 24 weeks	—

Secondary

Measure	Time frame
Measuring the psychometric properties of WHOQOL HIV Bref to improve the quality of life Timepoint: 24 weeks	—

Countries

India

Contacts

Public ContactDrBrajeshwar Mishra

YCB Ministry of AYUSH

dr.brajeshwarmishra@gmail.com8969127251

Outcome results